CAS: 2156634-62-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Befovacimab REF: TM-T76921CAS: 2156634-62-5 | - - - | To inquire | Mon 02 Dec 24 |
 | Befovacimab REF: 3D-CLA1584CAS: 2156634-62-5 | - - - | To inquire | Thu 12 Dec 24 |
Befovacimab
CAS:2156634-62-5
Befovacimab, a human IgG2 antibody, targets TFPI for hemophilia A/B research.
Color and Shape:
Liquid
Ref: TM-T76921
| 5mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
Befovacimab
CAS:2156634-62-5
Human monoclonal antibody targeting tissue factor pathway inhibitor (TFPI); non-replacement therapy for haemophilia A/B patients
Ref: 3D-CLA1584
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 12 Dec 2024
